(lp0
S'Regulus Therapeutics Inc.  Plunges 7.14% on March 15 Equities.com - Mar 15, 2017 Regulus Therapeutics Inc.  had a rough trading day for Wednesday March 15 as shares tumbled 7.14%, or a loss of $-0.1 per share, to close at $1.30.Noteworthy Stock: Regulus Therapeutics Inc.  - Is storiesNext Weeks Broker Price Targets For Regulus Therapeutics Inc.  - Fiscal Standard'
p1
aS'RGLS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a ... PR Newswire  - Mar 13, 2017 NEW YORK, March 13, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of California on behalf of investors who purchased Regulus Therapeutics Inc.'
p2
aS"Sell-Side Analyst's Predictions: Regulus Therapeutics Inc. , RH  The USA Commerce - Mar 17, 2017 Regulus Therapeutics Inc.  share price increased in the last trading session with a previous 52-week high of $8.90."
p3
aS'Regulus Therapeutics Inc.  Soars 13.04% on March 08 Equities.com - Mar 8, 2017 Regulus Therapeutics Inc.  had a good day on the market for Wednesday March 08 as shares jumped 13.04% to close at $1.30.Rating Change on Regulus Therapeutics Inc.  - Energy IndexFeatured Stock for Investors: Regulus Therapeutics Inc.  - HugoPress'
p4
aS"Regulus Reports Fourth Quarter 2016 Financial Results and Pipeline Update PR Newswire  - Mar 2, 2017 LA JOLLA, Calif., March 2, 2017 /PRNewswire/ -- Regulus Therapeutics Inc. , a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth&nbsp;...Regulus Therapeutics Inc.  Files An 8-K Results of Operations and ... - Market ExclusiveRegulus Therapeutics'  CEO Paul Grint on Q4 2016 Results - Earnings Call ... - Seeking Alpha"
p5
aS'Regulus Therapeutics Inc.  Soars 8% on March 13 Equities.com - Mar 13, 2017 Regulus Therapeutics Inc.  had a good day on the market for Monday March 13 as shares jumped 8% to close at $1.35. About 1.92 million shares traded hands on 4,580 trades for the day, compared with an average daily volume of 769,199 shares out&nbsp;...'
p6
aS'Regulus Therapeutics Inc.: Regulus to Release Fourth Quarter and Full Year ... The Wall Street Transcript - Feb 23, 2017 23, 2017 /PRNewswire/ -- Regulus Therapeutics Inc. , a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced it will release fourth quarter and full year 2016&nbsp;...Market Mover of Last Trading Session: Regulus Therapeutics Inc.  - Is stories'
p7
aS"Regulus Therapeutics Inc.  Moves Lower on Volume Spike for February 17 Equities.com - Feb 17, 2017 Regulus Therapeutics Inc.  traded on unusually high volume on Feb. 17, as the stock lost 4.17% to close at $1.15. On the day, Regulus Therapeutics Inc. saw 2.02 million shares trade hands on 2,856 trades. Considering that the stock averages only ...Average Brokerage Rating Of Regulus Therapeutics Inc. , California ... - The USA CommerceWall Street Analyst's Guidance: Regulus Therapeutics Inc. , KBR ... - TRA"
p8
aS'IMPORTANT SHAREHOLDER ALERT: Khang &amp; Khang LLP Announces Securities Class ... Yahoo Finance - Feb 27, 2017 IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang &amp; Khang LLP  announces the filing of a class action lawsuit against Regulus Therapeutics Inc.  . Investors, who purchased or otherwise&nbsp;...IMPORTANT EQUITY NOTICE: Lundin Law PC Announces Securities Class Action ... - Baystreet.ca'
p9
aS"What Type of Consensus Views Analysts Say about Regulus Therapeutics Inc.'s ... Hot Stocks Point - Mar 17, 2017 Regulus Therapeutics Inc.  stock price ended its day with no change 0.00% and finalized at the value of $1.30. During its last trading session, Stock traded with the total exchanged volume of 1.69 million shares."
p10
a.